$0.6996
0.1119.59%
At close: -
$0.6900
-0.00960-1.37%
After Hours: 7:00 PM EDT
ABVC BioPharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of ABVC BioPharma using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q2 | 2023-08-14 | $-0.68 | $-0.60 | -1333.3 % |
Q1 | 2023-05-15 | $-0.60 | $-0.50 | -2000.0 % |
Q4 | 2023-03-31 | $-1.50 | $-1.50 | 0.00 % |
Q3 | 2021-11-15 | $-0.70 | $-0.40 | -7500.0 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q2 | 2023-08-14 | $6.11K | $300.00K | -98.0 % |
Q1 | 2023-05-15 | $128.27K | $128.00K | 0.21 % |
Q4 | 2023-03-31 | $588.99K | $10.00K | 5789.9 % |
Q3 | 2021-11-15 | $99.00K | $190.00K | -47.9 % |
ABVC BioPharma (ABVC) is scheduled to report earnings on May 16, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
The Actual EPS was $-0.02, which missed the estimate of $0.00.
The Actual Revenue was $389.3K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.